Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $DFTX vs $OGN | Chartloom

Compare

$DFTX vs $OGN

Definium Therapeutics Inc · Organon & Co

DFTX

Definium Therapeutics Inc

OGN

Organon & Co

Compare $DFTX vs $OGN

Comparing Definium Therapeutics Inc and Organon & Co

DFTXDefinium Therapeutics Inc

OGNOrganon & Co

DFTXDefinium Therapeutics Inc

Market cap

$4.28B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

152.1%

52W performance

191.1%

FCF yield

-3.9%

OGNOrganon & Co

Market cap

$3.62B

P/E (TTM)

17.82x

Forward P/E (NTM)

3.84x

Forward P/S (NTM)

0.58x

Rev growth (TTM)

-2.5%

YTD performance

90.2%

52W performance

43.4%

FCF yield

12.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DFTX

OGN

Detailed metrics comparison

DFTX

Definium Therapeutics Inc

OGN

Organon & Co

Market Cap

DFTX$4.28B

OGN$3.62B

Enterprise Value

DFTX$3.67B

OGN$11.04B

Price

DFTX$34.38

OGN$13.77

P/E Ratio

DFTXN/A

OGN17.82x

P/S Ratio

DFTX0.00x

OGN0.59x

EV/Sales

DFTX0.00x

OGN1.80x

EV/EBITDA

DFTX0.00x

OGN6.50x

P/B Ratio

DFTX5.40x

OGN3.61x

P/FCF Ratio

DFTXN/A

OGN8.33x

EV/FCF

DFTX-21.83x

OGN25.43x

PEG Ratio

DFTXN/A

OGNN/A

Forward P/E (NTM)

DFTXN/A

OGN3.84x

Forward P/S (NTM)

DFTXN/A

OGN0.58x

Revenue (TTM)

DFTX$0

OGN$6.13B

Revenue Growth (YoY)

DFTXN/A

OGN-2.5%

Forward Rev Growth

DFTX717.7%

OGN1.6%

Gross Margin (TTM)

DFTX0.0%

OGN52.7%

Operating Margin (TTM)

DFTX0.0%

OGN8.0%

EBITDA Margin (TTM)

DFTX0.0%

OGN27.7%

Net Margin (TTM)

DFTX0.0%

OGN3.4%

FCF Margin (TTM)

DFTXN/A

OGN7.1%

Net Income (TTM)

DFTX$-354M

OGN$209M

FCF (TTM)

DFTX$-168M

OGN$434M

EPS (TTM)

DFTX-$3.20

OGN$0.77

ROE (TTM)

DFTX-8523.0%

OGN23.4%

ROA (TTM)

DFTX-6458.0%

OGN1.6%

ROIC (TTM)

DFTX-7781.0%

OGN2.2%

Cash

DFTX$655M

OGN$1.13B

Debt

DFTX$36M

OGN$8.55B

Net Cash/Debt

DFTX$619M

OGN$-7.42B

Current Ratio (TTM)

DFTX6.95x

OGN1.95x

Quick Ratio (TTM)

DFTX6.89x

OGN1.44x

Debt/Equity (TTM)

DFTX0.04x

OGN8.50x

Debt/Assets (TTM)

DFTX0.0%

OGN0.0%

Interest Coverage (TTM)

DFTXN/A

OGNN/A

Net Debt/EBITDA (TTM)

DFTX0.00x

OGN0.00x

Beta

DFTX2.23

OGN1.50

52W Performance

DFTX191.1%

OGN43.4%

YTD Performance

DFTX152.1%

OGN90.2%

% from 52W High

DFTX-30.8%

OGN-0.7%

% from 52W Low

DFTX228.5%

OGN142.0%

Asset Turnover (TTM)

DFTX0.00x

OGN0.47x

FCF Yield (TTM)

DFTX-3.9%

OGN12.0%

Earnings Yield (TTM)

DFTX-8.3%

OGN5.8%

Dividend Yield (TTM)

DFTXN/A

OGN0.5%

Rule of 40

DFTX0.0

OGN4.6

EV/GP/RG

DFTXN/A

OGN2.99

Ticker research

View DFTX research View OGN research

Metric	DFTX Definium Therapeutics Inc	OGN Organon & Co
Market & Valuation
Market Cap	$4.28B	$3.62B
Enterprise Value	$3.67B	$11.04B
Price	$34.38	$13.77
P/E Ratio	N/A	17.82x
P/S Ratio	0.00x	0.59x
EV/Sales	0.00x	1.80x
EV/EBITDA	0.00x	6.50x
P/B Ratio	5.40x	3.61x
P/FCF Ratio	N/A	8.33x
EV/FCF	-21.83x	25.43x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	3.84x
Forward P/S (NTM)	N/A	0.58x
Revenue & Growth
Revenue (TTM)	$0	$6.13B
Revenue Growth (YoY)	N/A	-2.5%
Forward Rev Growth	717.7%	1.6%
Profitability
Gross Margin (TTM)	0.0%	52.7%
Operating Margin (TTM)	0.0%	8.0%
EBITDA Margin (TTM)	0.0%	27.7%
Net Margin (TTM)	0.0%	3.4%
FCF Margin (TTM)	N/A	7.1%
Net Income (TTM)	$-354M	$209M
FCF (TTM)	$-168M	$434M
EPS (TTM)	-$3.20	$0.77
ROE (TTM)	-8523.0%	23.4%
ROA (TTM)	-6458.0%	1.6%
ROIC (TTM)	-7781.0%	2.2%
Financial Health
Cash	$655M	$1.13B
Debt	$36M	$8.55B
Net Cash/Debt	$619M	$-7.42B
Current Ratio (TTM)	6.95x	1.95x
Quick Ratio (TTM)	6.89x	1.44x
Debt/Equity (TTM)	0.04x	8.50x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.23	1.50
52W Performance	191.1%	43.4%
YTD Performance	152.1%	90.2%
% from 52W High	-30.8%	-0.7%
% from 52W Low	228.5%	142.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.47x
FCF Yield (TTM)	-3.9%	12.0%
Earnings Yield (TTM)	-8.3%	5.8%
Dividend Yield (TTM)	N/A	0.5%
Other
Rule of 40	0.0	4.6
EV/GP/RG	N/A	2.99
Ticker research	View DFTX research	View OGN research

Valuation

P/E Ratio

OGN

17.82x

P/S Ratio

DFTX

0.00x

OGN

0.59x

EV/FCF

DFTX

-21.83x

OGN

25.43x

Growth & revenue

Revenue Growth TTM

OGN

-2.5%

Forward Revenue Growth

DFTX

717.7%

OGN

1.6%

Profitability & performance

Gross Margin

OGN

52.7%

DFTX

0.0%

ROE

OGN

23.4%

DFTX

-8523.0%

FCF Yield %

OGN

12.0%

DFTX

-3.9%

52-Week Performance

DFTX

191.1%

OGN

43.4%

Detailed metrics comparison

DFTX

Definium Therapeutics Inc

OGN

Organon & Co

Market Cap

DFTX$4.28B

OGN$3.62B

Enterprise Value

DFTX$3.67B

OGN$11.04B

Price

DFTX$34.38

OGN$13.77

P/E Ratio

DFTXN/A

OGN17.82x

P/S Ratio

DFTX0.00x

OGN0.59x

EV/Sales

DFTX0.00x

OGN1.80x

EV/EBITDA

DFTX0.00x

OGN6.50x

P/B Ratio

DFTX5.40x

OGN3.61x

P/FCF Ratio

DFTXN/A

OGN8.33x

EV/FCF

DFTX-21.83x

OGN25.43x

PEG Ratio

DFTXN/A

OGNN/A

Forward P/E (NTM)

DFTXN/A

OGN3.84x

Forward P/S (NTM)

DFTXN/A

OGN0.58x

Revenue (TTM)

DFTX$0

OGN$6.13B

Revenue Growth (YoY)

DFTXN/A

OGN-2.5%

Forward Rev Growth

DFTX717.7%

OGN1.6%

Gross Margin (TTM)

DFTX0.0%

OGN52.7%

Operating Margin (TTM)

DFTX0.0%

OGN8.0%

EBITDA Margin (TTM)

DFTX0.0%

OGN27.7%

Net Margin (TTM)

DFTX0.0%

OGN3.4%

FCF Margin (TTM)

DFTXN/A

OGN7.1%

Net Income (TTM)

DFTX$-354M

OGN$209M

FCF (TTM)

DFTX$-168M

OGN$434M

EPS (TTM)

DFTX-$3.20

OGN$0.77

ROE (TTM)

DFTX-8523.0%

OGN23.4%

ROA (TTM)

DFTX-6458.0%

OGN1.6%

ROIC (TTM)

DFTX-7781.0%

OGN2.2%

Cash

DFTX$655M

OGN$1.13B

Debt

DFTX$36M

OGN$8.55B

Net Cash/Debt

DFTX$619M

OGN$-7.42B

Current Ratio (TTM)

DFTX6.95x

OGN1.95x

Quick Ratio (TTM)

DFTX6.89x

OGN1.44x

Debt/Equity (TTM)

DFTX0.04x

OGN8.50x

Debt/Assets (TTM)

DFTX0.0%

OGN0.0%

Interest Coverage (TTM)

DFTXN/A

OGNN/A

Net Debt/EBITDA (TTM)

DFTX0.00x

OGN0.00x

Beta

DFTX2.23

OGN1.50

52W Performance

DFTX191.1%

OGN43.4%

YTD Performance

DFTX152.1%

OGN90.2%

% from 52W High

DFTX-30.8%

OGN-0.7%

% from 52W Low

DFTX228.5%

OGN142.0%

Asset Turnover (TTM)

DFTX0.00x

OGN0.47x

FCF Yield (TTM)

DFTX-3.9%

OGN12.0%

Earnings Yield (TTM)

DFTX-8.3%

OGN5.8%

Dividend Yield (TTM)

DFTXN/A

OGN0.5%

Rule of 40

DFTX0.0

OGN4.6

EV/GP/RG

DFTXN/A

OGN2.99

Ticker research

View DFTX research View OGN research

Metric	DFTX Definium Therapeutics Inc	OGN Organon & Co
Market & Valuation
Market Cap	$4.28B	$3.62B
Enterprise Value	$3.67B	$11.04B
Price	$34.38	$13.77
P/E Ratio	N/A	17.82x
P/S Ratio	0.00x	0.59x
EV/Sales	0.00x	1.80x
EV/EBITDA	0.00x	6.50x
P/B Ratio	5.40x	3.61x
P/FCF Ratio	N/A	8.33x
EV/FCF	-21.83x	25.43x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	3.84x
Forward P/S (NTM)	N/A	0.58x
Revenue & Growth
Revenue (TTM)	$0	$6.13B
Revenue Growth (YoY)	N/A	-2.5%
Forward Rev Growth	717.7%	1.6%
Profitability
Gross Margin (TTM)	0.0%	52.7%
Operating Margin (TTM)	0.0%	8.0%
EBITDA Margin (TTM)	0.0%	27.7%
Net Margin (TTM)	0.0%	3.4%
FCF Margin (TTM)	N/A	7.1%
Net Income (TTM)	$-354M	$209M
FCF (TTM)	$-168M	$434M
EPS (TTM)	-$3.20	$0.77
ROE (TTM)	-8523.0%	23.4%
ROA (TTM)	-6458.0%	1.6%
ROIC (TTM)	-7781.0%	2.2%
Financial Health
Cash	$655M	$1.13B
Debt	$36M	$8.55B
Net Cash/Debt	$619M	$-7.42B
Current Ratio (TTM)	6.95x	1.95x
Quick Ratio (TTM)	6.89x	1.44x
Debt/Equity (TTM)	0.04x	8.50x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.23	1.50
52W Performance	191.1%	43.4%
YTD Performance	152.1%	90.2%
% from 52W High	-30.8%	-0.7%
% from 52W Low	228.5%	142.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.47x
FCF Yield (TTM)	-3.9%	12.0%
Earnings Yield (TTM)	-8.3%	5.8%
Dividend Yield (TTM)	N/A	0.5%
Other
Rule of 40	0.0	4.6
EV/GP/RG	N/A	2.99
Ticker research	View DFTX research	View OGN research